These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3962459)

  • 1. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
    Fagrell B; Lundberg G; Olsson A; Ostergren J
    Vasa; 1986; 15(1):56-60. PubMed ID: 3962459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Klin Wochenschr; 1990 Feb; 68(4):207-12. PubMed ID: 2314008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short- and long-term evaluation of treatment of critical ischemia of the lower lim with PGE1 (alprostadyl alpha-cyclodestrine)].
    Amitrano M; Izzo M; Castaldo G; Lombardi R; Tizzano R; Bellizzi AM; Vietri GC; Sorrentino A; D'Avanzo A
    Minerva Cardioangiol; 1996; 44(7-8):391-6. PubMed ID: 8965998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of thrombinic activation indexes, in patients with lower limb critic ischaemia, before and after prostaglandin E1 therapy.
    Trifiletti A; Bartolone S; Scamardi R; Pizzoleo MA; Attinà A; Sottilotta G; Canobbio V; Soraci S; Barbera N
    Minerva Cardioangiol; 1999 Mar; 47(3):55-8. PubMed ID: 10389444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P; Birkel L; Grub KR; de la Hamette D
    Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transcutaneous oxygen pressure during intra-arterial infusions].
    Creutzig A; Dau D; Alexander K
    Vasa; 1984; 13(3):207-12. PubMed ID: 6485524
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of the treatment of peripheral arterial diseases with PGE1].
    Borkowski M; Kruk M; Królicki L; Wojtal E; Malmurowicz L; Górewicz R; Laszuk D
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):505-8. PubMed ID: 2287566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H; Brodel C; Meuche C; Hellmann G; Ranft J
    Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A; Caspary L; Alexander K
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract]   [Full Text] [Related]  

  • 16. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
    Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
    Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbances of skin microcirculation in patients with chronic arterial occlusive disease and venous incompetence.
    Creutzig A; Caspary L; Alexander K
    Vasa; 1988; 17(2):77-83. PubMed ID: 3407317
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
    Laurora G; Cesarone MR; Belcaro G; Incandela L; De Sanctis MT; Fascetti E; D'Archivio C
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S; Claeys L
    Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].
    Kozlitskiĭ AP
    Vestn Khir Im I I Grek; 1982 Sep; 129(9):120-3. PubMed ID: 7147583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.